Clinical Trial

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Summary
This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-20; most recent amendment 2026-01-21.
Status change: Active, Not Recruiting → Recruiting 2022-08-10
Trial Details
NCT Number NCT05343598
Lead Sponsor Mclean Hospital
Collaborators: Beth Israel Deaconess Medical Center, National Institute of Mental Health (NIMH)
Conditions Schizophrenia, Schizo Affective Disorder
Enrollment 68 participants
Start Date 2021-10-13
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-22